Loading…
Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective
Objective To describe the outcome of pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT) in relation to the invasiveness of the management protocol. Design Retrospective analysis of prospectively collected data from a national cohort. Setting Leiden University Medical Centre,...
Saved in:
Published in: | BJOG : an international journal of obstetrics and gynaecology 2007-04, Vol.114 (4), p.469-473 |
---|---|
Main Authors: | , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543 |
---|---|
cites | cdi_FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543 |
container_end_page | 473 |
container_issue | 4 |
container_start_page | 469 |
container_title | BJOG : an international journal of obstetrics and gynaecology |
container_volume | 114 |
creator | Van Den Akker, ESA Oepkes, D Lopriore, E Brand, A Kanhai, HHH |
description | Objective To describe the outcome of pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT) in relation to the invasiveness of the management protocol.
Design Retrospective analysis of prospectively collected data from a national cohort.
Setting Leiden University Medical Centre, the national centre for management of severe red cell and platelet alloimmunisation in pregnancy.
Population Ninety‐eight pregnancies in 85 women with FNAIT having a previous child with thrombocytopenia with (n= 16) or without (n= 82) an intracranial haemorrhage (ICH).
Methods Our management protocol evolved over time from (1) serial fetal blood samplings (FBS) and platelet transfusion (n= 13) via (2) combined FBS with maternal intravenous immunoglobulins (n= 33) to (3) completely noninvasive treatment with immunoglobulins only (n= 52 pregnancies, resulting in 53 neonates). Perinatal outcome was assessed according to the three types of management.
Main outcome measures Occurrence of ICH, perinatal survival, gestational age at birth and complications of FBS.
Results All but one of 98 pregnancies ended in a live birth; none of the neonates had an ICH. The median gestational age at birth was 37 weeks (range 32–40). In groups 1 and 2, three emergency caesarean sections were performed after complicated FBS, resulting in two healthy babies and one neonatal death.
Conclusion Noninvasive antenatal management of pregnancies complicated by FNAIT appears to be both effective and safe. |
doi_str_mv | 10.1111/j.1471-0528.2007.01244.x |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_70301441</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>70301441</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543</originalsourceid><addsrcrecordid>eNqN0U1v1DAQBmALUdFS-AsoQoJb0vFX4iBxgIqvqqIXOFuTZAxZJfYSJ6X773F2V1TiQn3xyH48GutlLONQ8LQuNgVXFc9BC1MIgKoALpQq7h6xs78Xj_c15CCFOWVPY9wA8FKAfMJOeSWh1kqfMfc1-N7fYuxvKUM_k8cZh2xEjz9oJD9nwWWO1jP0XeYpHAAOQ-jHcfGUzT-nMDah3c1hS77HN1lER3tOzlE7p9bP2InDIdLz437Ovn_88O3yc3598-nL5bvrvFVaqxxb0gh119VQNQoViLpT0FAqUXR1iRrRNEIhhw4lSV26rtOmMg2W0mglz9nrQ9_tFH4tFGc79rGlYcA0-RJtBRK4Uvy_UEBSRtQJvvwHbsIy-fQJK4QuuSjLMiFzQO0UYpzI2e3UjzjtLAe7JmY3dg3GrsHYNTG7T8zepacvjv2XZqTu_uExogReHQHGFgc3oW_7eO-MNoZLmdzbg_vdD7R78AD2_dXNWsk_8Dix8g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>225612666</pqid></control><display><type>article</type><title>Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Van Den Akker, ESA ; Oepkes, D ; Lopriore, E ; Brand, A ; Kanhai, HHH</creator><creatorcontrib>Van Den Akker, ESA ; Oepkes, D ; Lopriore, E ; Brand, A ; Kanhai, HHH</creatorcontrib><description>Objective To describe the outcome of pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT) in relation to the invasiveness of the management protocol.
Design Retrospective analysis of prospectively collected data from a national cohort.
Setting Leiden University Medical Centre, the national centre for management of severe red cell and platelet alloimmunisation in pregnancy.
Population Ninety‐eight pregnancies in 85 women with FNAIT having a previous child with thrombocytopenia with (n= 16) or without (n= 82) an intracranial haemorrhage (ICH).
Methods Our management protocol evolved over time from (1) serial fetal blood samplings (FBS) and platelet transfusion (n= 13) via (2) combined FBS with maternal intravenous immunoglobulins (n= 33) to (3) completely noninvasive treatment with immunoglobulins only (n= 52 pregnancies, resulting in 53 neonates). Perinatal outcome was assessed according to the three types of management.
Main outcome measures Occurrence of ICH, perinatal survival, gestational age at birth and complications of FBS.
Results All but one of 98 pregnancies ended in a live birth; none of the neonates had an ICH. The median gestational age at birth was 37 weeks (range 32–40). In groups 1 and 2, three emergency caesarean sections were performed after complicated FBS, resulting in two healthy babies and one neonatal death.
Conclusion Noninvasive antenatal management of pregnancies complicated by FNAIT appears to be both effective and safe.</description><identifier>ISSN: 1470-0328</identifier><identifier>EISSN: 1471-0528</identifier><identifier>DOI: 10.1111/j.1471-0528.2007.01244.x</identifier><identifier>PMID: 17309545</identifier><identifier>CODEN: BIOGFQ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Alloimmune thrombocytopenia ; Antibodies - blood ; Antigens, Human Platelet - immunology ; Biological and medical sciences ; Blood tests ; Female ; fetal blood sampling ; Fetal Diseases - therapy ; Gestational Age ; Gynecology. Andrology. Obstetrics ; Hematologic and hematopoietic diseases ; HPA‐1a ; Humans ; Infant, Newborn ; intracranial haemorrhage ; intravenous immunoglobulins ; Medical sciences ; Neonatal care ; noninvasive treatment ; Obstetrics ; Platelet diseases and coagulopathies ; Platelet Transfusion ; Pregnancy ; Pregnancy Outcome ; Prenatal care ; Prenatal Care - methods ; Prospective Studies ; Retrospective Studies ; Thrombocytopenia - embryology ; Thrombocytopenia - therapy</subject><ispartof>BJOG : an international journal of obstetrics and gynaecology, 2007-04, Vol.114 (4), p.469-473</ispartof><rights>RCOG 2007 BJOG An International Journal of Obstetrics and Gynaecology</rights><rights>2007 INIST-CNRS</rights><rights>2007 The Authors Journal compilation</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543</citedby><cites>FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,777,781,27905,27906</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=18588133$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/17309545$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Van Den Akker, ESA</creatorcontrib><creatorcontrib>Oepkes, D</creatorcontrib><creatorcontrib>Lopriore, E</creatorcontrib><creatorcontrib>Brand, A</creatorcontrib><creatorcontrib>Kanhai, HHH</creatorcontrib><title>Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective</title><title>BJOG : an international journal of obstetrics and gynaecology</title><addtitle>BJOG</addtitle><description>Objective To describe the outcome of pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT) in relation to the invasiveness of the management protocol.
Design Retrospective analysis of prospectively collected data from a national cohort.
Setting Leiden University Medical Centre, the national centre for management of severe red cell and platelet alloimmunisation in pregnancy.
Population Ninety‐eight pregnancies in 85 women with FNAIT having a previous child with thrombocytopenia with (n= 16) or without (n= 82) an intracranial haemorrhage (ICH).
Methods Our management protocol evolved over time from (1) serial fetal blood samplings (FBS) and platelet transfusion (n= 13) via (2) combined FBS with maternal intravenous immunoglobulins (n= 33) to (3) completely noninvasive treatment with immunoglobulins only (n= 52 pregnancies, resulting in 53 neonates). Perinatal outcome was assessed according to the three types of management.
Main outcome measures Occurrence of ICH, perinatal survival, gestational age at birth and complications of FBS.
Results All but one of 98 pregnancies ended in a live birth; none of the neonates had an ICH. The median gestational age at birth was 37 weeks (range 32–40). In groups 1 and 2, three emergency caesarean sections were performed after complicated FBS, resulting in two healthy babies and one neonatal death.
Conclusion Noninvasive antenatal management of pregnancies complicated by FNAIT appears to be both effective and safe.</description><subject>Alloimmune thrombocytopenia</subject><subject>Antibodies - blood</subject><subject>Antigens, Human Platelet - immunology</subject><subject>Biological and medical sciences</subject><subject>Blood tests</subject><subject>Female</subject><subject>fetal blood sampling</subject><subject>Fetal Diseases - therapy</subject><subject>Gestational Age</subject><subject>Gynecology. Andrology. Obstetrics</subject><subject>Hematologic and hematopoietic diseases</subject><subject>HPA‐1a</subject><subject>Humans</subject><subject>Infant, Newborn</subject><subject>intracranial haemorrhage</subject><subject>intravenous immunoglobulins</subject><subject>Medical sciences</subject><subject>Neonatal care</subject><subject>noninvasive treatment</subject><subject>Obstetrics</subject><subject>Platelet diseases and coagulopathies</subject><subject>Platelet Transfusion</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome</subject><subject>Prenatal care</subject><subject>Prenatal Care - methods</subject><subject>Prospective Studies</subject><subject>Retrospective Studies</subject><subject>Thrombocytopenia - embryology</subject><subject>Thrombocytopenia - therapy</subject><issn>1470-0328</issn><issn>1471-0528</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2007</creationdate><recordtype>article</recordtype><recordid>eNqN0U1v1DAQBmALUdFS-AsoQoJb0vFX4iBxgIqvqqIXOFuTZAxZJfYSJ6X773F2V1TiQn3xyH48GutlLONQ8LQuNgVXFc9BC1MIgKoALpQq7h6xs78Xj_c15CCFOWVPY9wA8FKAfMJOeSWh1kqfMfc1-N7fYuxvKUM_k8cZh2xEjz9oJD9nwWWO1jP0XeYpHAAOQ-jHcfGUzT-nMDah3c1hS77HN1lER3tOzlE7p9bP2InDIdLz437Ovn_88O3yc3598-nL5bvrvFVaqxxb0gh119VQNQoViLpT0FAqUXR1iRrRNEIhhw4lSV26rtOmMg2W0mglz9nrQ9_tFH4tFGc79rGlYcA0-RJtBRK4Uvy_UEBSRtQJvvwHbsIy-fQJK4QuuSjLMiFzQO0UYpzI2e3UjzjtLAe7JmY3dg3GrsHYNTG7T8zepacvjv2XZqTu_uExogReHQHGFgc3oW_7eO-MNoZLmdzbg_vdD7R78AD2_dXNWsk_8Dix8g</recordid><startdate>200704</startdate><enddate>200704</enddate><creator>Van Den Akker, ESA</creator><creator>Oepkes, D</creator><creator>Lopriore, E</creator><creator>Brand, A</creator><creator>Kanhai, HHH</creator><general>Blackwell Publishing Ltd</general><general>Blackwell</general><general>Wiley Subscription Services, Inc</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>K9.</scope><scope>7T5</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>200704</creationdate><title>Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective</title><author>Van Den Akker, ESA ; Oepkes, D ; Lopriore, E ; Brand, A ; Kanhai, HHH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2007</creationdate><topic>Alloimmune thrombocytopenia</topic><topic>Antibodies - blood</topic><topic>Antigens, Human Platelet - immunology</topic><topic>Biological and medical sciences</topic><topic>Blood tests</topic><topic>Female</topic><topic>fetal blood sampling</topic><topic>Fetal Diseases - therapy</topic><topic>Gestational Age</topic><topic>Gynecology. Andrology. Obstetrics</topic><topic>Hematologic and hematopoietic diseases</topic><topic>HPA‐1a</topic><topic>Humans</topic><topic>Infant, Newborn</topic><topic>intracranial haemorrhage</topic><topic>intravenous immunoglobulins</topic><topic>Medical sciences</topic><topic>Neonatal care</topic><topic>noninvasive treatment</topic><topic>Obstetrics</topic><topic>Platelet diseases and coagulopathies</topic><topic>Platelet Transfusion</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome</topic><topic>Prenatal care</topic><topic>Prenatal Care - methods</topic><topic>Prospective Studies</topic><topic>Retrospective Studies</topic><topic>Thrombocytopenia - embryology</topic><topic>Thrombocytopenia - therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Van Den Akker, ESA</creatorcontrib><creatorcontrib>Oepkes, D</creatorcontrib><creatorcontrib>Lopriore, E</creatorcontrib><creatorcontrib>Brand, A</creatorcontrib><creatorcontrib>Kanhai, HHH</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Van Den Akker, ESA</au><au>Oepkes, D</au><au>Lopriore, E</au><au>Brand, A</au><au>Kanhai, HHH</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective</atitle><jtitle>BJOG : an international journal of obstetrics and gynaecology</jtitle><addtitle>BJOG</addtitle><date>2007-04</date><risdate>2007</risdate><volume>114</volume><issue>4</issue><spage>469</spage><epage>473</epage><pages>469-473</pages><issn>1470-0328</issn><eissn>1471-0528</eissn><coden>BIOGFQ</coden><abstract>Objective To describe the outcome of pregnancies with fetal and neonatal alloimmune thrombocytopenia (FNAIT) in relation to the invasiveness of the management protocol.
Design Retrospective analysis of prospectively collected data from a national cohort.
Setting Leiden University Medical Centre, the national centre for management of severe red cell and platelet alloimmunisation in pregnancy.
Population Ninety‐eight pregnancies in 85 women with FNAIT having a previous child with thrombocytopenia with (n= 16) or without (n= 82) an intracranial haemorrhage (ICH).
Methods Our management protocol evolved over time from (1) serial fetal blood samplings (FBS) and platelet transfusion (n= 13) via (2) combined FBS with maternal intravenous immunoglobulins (n= 33) to (3) completely noninvasive treatment with immunoglobulins only (n= 52 pregnancies, resulting in 53 neonates). Perinatal outcome was assessed according to the three types of management.
Main outcome measures Occurrence of ICH, perinatal survival, gestational age at birth and complications of FBS.
Results All but one of 98 pregnancies ended in a live birth; none of the neonates had an ICH. The median gestational age at birth was 37 weeks (range 32–40). In groups 1 and 2, three emergency caesarean sections were performed after complicated FBS, resulting in two healthy babies and one neonatal death.
Conclusion Noninvasive antenatal management of pregnancies complicated by FNAIT appears to be both effective and safe.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>17309545</pmid><doi>10.1111/j.1471-0528.2007.01244.x</doi><tpages>5</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1470-0328 |
ispartof | BJOG : an international journal of obstetrics and gynaecology, 2007-04, Vol.114 (4), p.469-473 |
issn | 1470-0328 1471-0528 |
language | eng |
recordid | cdi_proquest_miscellaneous_70301441 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Alloimmune thrombocytopenia Antibodies - blood Antigens, Human Platelet - immunology Biological and medical sciences Blood tests Female fetal blood sampling Fetal Diseases - therapy Gestational Age Gynecology. Andrology. Obstetrics Hematologic and hematopoietic diseases HPA‐1a Humans Infant, Newborn intracranial haemorrhage intravenous immunoglobulins Medical sciences Neonatal care noninvasive treatment Obstetrics Platelet diseases and coagulopathies Platelet Transfusion Pregnancy Pregnancy Outcome Prenatal care Prenatal Care - methods Prospective Studies Retrospective Studies Thrombocytopenia - embryology Thrombocytopenia - therapy |
title | Noninvasive antenatal management of fetal and neonatal alloimmune thrombocytopenia: safe and effective |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T09%3A58%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Noninvasive%20antenatal%20management%20of%20fetal%20and%20neonatal%20alloimmune%20thrombocytopenia:%20safe%20and%20effective&rft.jtitle=BJOG%20:%20an%20international%20journal%20of%20obstetrics%20and%20gynaecology&rft.au=Van%20Den%20Akker,%20ESA&rft.date=2007-04&rft.volume=114&rft.issue=4&rft.spage=469&rft.epage=473&rft.pages=469-473&rft.issn=1470-0328&rft.eissn=1471-0528&rft.coden=BIOGFQ&rft_id=info:doi/10.1111/j.1471-0528.2007.01244.x&rft_dat=%3Cproquest_cross%3E70301441%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4554-ace5a09dd907b4a4029d40be4a4a2d96a5aa8b24a10da3e356fdd5878ba638543%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=225612666&rft_id=info:pmid/17309545&rfr_iscdi=true |